Diferencia entre revisiones de «Template:Cryptococcus Meningitis»

(Convert to AntibioticDose with disease=Cryptococcosis for SMW linking)
(Add pediatric cryptococcal meningitis dosing)
 
Línea 7: Línea 7:
**Followed by {{AntibioticDose|disease=Cryptococcosis|drug=Fluconazole|dose=400mg PO q24hrs x 8 weeks|context=Meningitis consolidation with AIDS|population=Adult}}
**Followed by {{AntibioticDose|disease=Cryptococcosis|drug=Fluconazole|dose=400mg PO q24hrs x 8 weeks|context=Meningitis consolidation with AIDS|population=Adult}}
*Initiation of HAART is delayed by 2 to 10 weeks to minimize the risk of immune reconstitution syndrome
*Initiation of HAART is delayed by 2 to 10 weeks to minimize the risk of immune reconstitution syndrome
===Pediatric Cryptococcal Meningitis===
*{{AntibioticDose|disease=Cryptococcosis|drug=Amphotericin B|dose=0.7-1mg/kg IV daily x 2-4 weeks|context=Pediatric Meningitis|population=Pediatric}} + Flucytosine 25mg/kg PO q6hrs
**Followed by {{AntibioticDose|disease=Cryptococcosis|drug=Fluconazole|dose=6-12mg/kg PO daily x 8 weeks (max 400mg)|context=Pediatric Consolidation|population=Pediatric}}

Revisión actual - 13:21 20 mar 2026

Meningitis (not AIDs associated)

  • Amphotericin B 0.7-1mg/kg IV q24hrs AND Flucytosine 25mg/kg PO q6hrs x 4 weeks

Meningitis (with AIDS)

  • Amphotericin B 0.7-1mg/kg IV q24hrs AND Flucytosine 25mg/kg PO q6hrs x 2 weeks
  • Initiation of HAART is delayed by 2 to 10 weeks to minimize the risk of immune reconstitution syndrome

Pediatric Cryptococcal Meningitis

  • Amphotericin B 0.7-1mg/kg IV daily x 2-4 weeks + Flucytosine 25mg/kg PO q6hrs
    • Followed by Fluconazole 6-12mg/kg PO daily x 8 weeks (max 400mg)